Researchers at the Hebrew University of Jerusalem have developed a molecule known as NT157 which targets metastatic human melanoma and colon cancer. The molecule has been licensed to Israeli startup TyrNovo for medical trials.
https://www.afhu.org/internationally-acclaimed-researchers-discover-a-double-anti-cancer-agent/news/